Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

Technology appraisal guidance
Reference number: TA225
Published: 22 June 2011

Report on the additional data and data requested following the second committee meeting produced by the School of Health and Related Research (ScHARR)

Report on the additional data and data requested following the second committee meeting produced by the School of Health and Related Research (ScHARR)

Report on the additional data and data requested following the second committee meeting produced by the School of Health and Related Research (ScHARR)
13 May 2011
(579.03 Kb 48 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 May 2011